BioVie reports topline Phase 2 SUNRISE-PD results for bezisterim in early Parkinson's diseaseAug 6Clinical readoutbezisterimBiovie Inc.
Supernus sets August 4 date for second-quarter 2026 resultsJul 22Quarterly updateSupernus Pharmaceuticals, Inc.
Sign inSign in